Iron may induce both DNA synthesis and repair in rat hepatocytes stimulated by EGF/pyruvate

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 650-658

  Chenoufi, Norchen ^a   Loréal, Olivier ^a   Drénou, Bernard ^b   Cariou, Sandrine ^a   Hubert, Noëlla ^a   Leroyer, Patricia ^a,b   Brissot, Pierre ^a,b   Lescoat, Gérard ^a  

^a INSERM   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

DNA; hepatocellular carcinoma; iron; rat hepatocytes

Indexed keywords

EPIDERMAL GROWTH FACTOR; HYDROXYUREA; IRON; PYRUVIC ACID;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; DNA REPAIR; DNA SYNTHESIS; FLOW CYTOMETRY; HEMOCHROMATOSIS; IRON OVERLOAD; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0343471371     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80432-1     Document Type: Article

References (61)

1. Simon M, Brissot P. The genetics of haemochromatosis. J Hepatol. 6:1988;116-124.
2. Brissot P, Deugnier Y. Genetic haemochromatosis. McIntyre N, Bircher J, Rizzetto M, Rodes J. Oxford Textbook of Clinical Hepatology. 1992;948-958 Oxford University Press.
3. Bomford A, Williams R. Long-term results of venesection therapy in idiopathic haemochromatosis. Q J Med. 45:1976;611-623.
4. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med. 313:1985;1256-1262.
5. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology. 15:1992;655-689.
6. Deugnier Y, Guyader D, Crantock L, Lopez JM, Turlin B, Yaouanq J, Jouanolle H, Campion JP, Launois B, Halliday JW, Powell LW, Brissot P. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases. Gastroenterology. 104:1993;228-234.
7. Turlin B, Juguet F, Moirand R, Lequilleuc D, Loréal O, Campion JP, Launois B, Ramée MP, Deugnier Y. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology. 22:1995;446-450.
8. Gonzales J, Behirschke K, Saltman P, Roberts J, Robinson P. Hemosiderosis in lemurs. Zoo Biol. 3:1984;255-265.
9. Thompson HJ, Kennedy K, Witt M, Juzefyk J. Effect of dietary iron deficiency or excess on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis. 12:1991;111-114.
10. Hann H, Stahlhut M, Blumberg B. Iron nutrition and tumor growth: decreased tumor growth in iron deficient mice. Cancer Res. 48:1988;4168-4170.
11. Yoshiji H, Nakae D, Kinugasa T, Matsuzaki M, Denda A, Tsuji T, Konishi Y. Inhibitory effect of dietary iron deficiency on the induction of putative preneoplastic foci in rat liver initiated with diethylnitrosamine and promoted by phenobarbital. Br J Cancer. 64:1991;839-842.
12. Park CH, Bacon BR, Brittenham GM, Tavill AS. Pathology of dietary carbonyl iron overload in rats. Lab Invest. 57:1987;555-563.
13. Pietrangelo P, Rocchi E, Schiaffonati L, Ventura E, Cairo G. Liver gene expression during chronic dietary iron overload in rats. Hepatology. 11:1990;798-804.
14. Brown EB, Dubac R, Smith DE, Moore C, Reynafarge C, Moore CV. Studies in iron transportation and metabolism. X Long-term iron overload in dogs. J Lab Clin Med. 50:1957;862-893.
15. Goldberg L, Smith JP, Martin L. The effects of intensive and prolonged administration of iron parenterally in animals. Br J Exp Pathol. 38:1957;297-311.
16. Brissot P, Farjanel, Bourel D, Campion JP, Guillouzo A, Rattner A, Deugnier Y, Desvergne B, Ferrand B, Simon M, Bourel M. Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional charges with special reference to collagen synthesis enzyme. Dig Dis Sci. 32:1987;620-627.
17. Iancu TC, Ward RJ, Peters TJ. Ultrastructural observations in the carbonyl iron-fed rat, an animal model for hemochromatosis. Virchows Arch B. 53:1987;208-217.
18. Cazzola M, Bergamaschi G, Dezza L, Arosio P. Manipulations of cellular iron metabolism for modulating normal and malignant cell proliferation: achievement and prospects. Blood. 75:1990;1903-1919.
19. Hann HL, Stahlhut MW, Hann CL. Effect of iron and desferrioxamine on cell growth and in vitro ferritin synthesis in human hepatoma cell lines. Hepatology. 11:1990;566-569.
20. Alcain FJ, Low H, Crane FL. Iron at the cell surface controls DNA synthesis in CCl 39 cells. Biochem Biophys Res Commun. 203:1994;16-21.
21. Alcain FJ, Low H, Crane FL. Iron reverses impermeable chelator inhibition of DNA synthesis in CCl 39 cells. Proc Natl Acad Sci. 91:1994;7903-7906.
22. Nishiya Koji. Stimulation of human synovial cell DNA synthesis by iron. J Rheumatol. 21:1994;1802-1807.
23. Popper H. Pathological aspects of cirrhosis. Am J Pathol. 87:1977;228-258.
24. Francavilla A, Ove P, Polimento L. Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy. Cancer Res. 46:1986;1318-1323.
25. McGowan JA, Strain AJ, Bucher NL. DNA synthesis in primary cultures of adult hepatocytes in a defined medium: effects of epidermal growth factor, insulin, glucagon and cyclic-AMP. J Cell Physiol. 108:1981;353-363.
26. Chan K, Kost DP, Michalopoulos G. Multiple sequential periods of DNA synthesis and quiescence in primary hepatocyte cultures maintained on the DMSO-DGF on/off protocol. J Cell Physiol. 141:1989;584-590.
27. Loyer P, Cariou S, Glaise D, Bilodeau M, Baffet G, Guguen-Guillouzo C. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid late G1. J Biol Chem. 271:1996;11484-11492.
28. Seglen PO. Preparation of rat liver cells. Enzymatic requirement of tissue dispersion. Exp Cell Res. 82:1973;391-398.
29. Guguen C, Guillouzo A, Boisnard M, Le Cam A, Bourel M. Etude ultrastructurale de monocouches d'hépatocytes de rat adulte cultivés en présence d'hémisuccinate d'hydrocortisone. Biol Gastroenterol. 8:1975;223-231.
30. Azari P, Baugh RF. A simple and rapid procedure for preparation of large quantities of pure ovotransferrin. Arch Biochem Biophys. 118:1967;138-144.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
32. Loyer P, Glaise D, Cariou S, Meijer L, Guguen-Guillouzo C. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem. 269:1994;2491-2500.
33. Alati T, Eckl P, Jirtle RL. An in vitro micronucleus assay for determining the radiosensitivity of hepatocytes. Radiat Res. 119:1989;562-568.
34. Nyholm S, Thelander L, Gräslund A. Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea. Biochemistry. 32:1993;11569-11574.
35. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Ann Rev Biochem. 57:1988;349-374.
36. Vindelov LL, Christensen IJ, Nissen NJ. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometric. 3:1983;323-327.
37. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, Halliday JW, Basset ML, Powell LW. Cohort study of internal malignancy in genetic hemochromatosis and other chronic non-alcoholic liver diseases. J Natl Cancer. 75:1985;81-84.
38. Batey RG, Lai Chung Fong L, Shamir S, Sherlock S. A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci. 25:1980;340-346.
39. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Salder PJ. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J Biol Chem. 264:1989;4417-4422.
40. Brissot P, Wright TL, Ma WL, Weisiger RA. Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states. J Clin Invest. 76:1985;1463-1470.
41. Wright TL, Brissot P, Ma WL, Weisiger RA. Characterisation of non-transferrin-bound iron clearance by rat liver. J Biol Chem. 261:1986;10909-10914.
42. Craven CM, Alexander J, Eldridge M, Kushner JP, Bernstein S, Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc Natl Acad Sci USA. 84:1987;3457-3461.
43. Sarkar B. State of iron (III) in normal human serum: low molecular weight and protein ligands besides transferrin. Can J Biochem. 48:1970;1339-1350.
44. Spiro T, Pape L, Saltman P. The hydrolytic polymerization of ferric citrate. I. The chemistry of the polymers. J Am Chem Soc. 89:1967;5555-5559.
45. Hubert N, Lescoat G, Sciot R, Moirand R, Jego P, Leroyer P, Brissot P. Regulation of ferritin and transferrin receptor expression by iron in human hepatocyte cultures. J Hepatol. 18:1993;301-312.
46. Chenoufi N, Hubert N, Loréal O, Morel I, Pasdeloup N, Cillard J, Brissot P, Lescoat G. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin - 4-ones CP20 and CP94. J Hepatol. 23:1995;166-173.
47. Stål P, Hultcrantz R, Möller L, Eriksson LC. The effects of dietary iron on initiation and promotion in chemical hepatocarcinogenesis. Hepatology. 21:1995;521-528.
48. Nyholm S, Mann GJ, Johansson AG, Bergeron RJ, Gräslund A, Thelander L. Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent chelators. J Biol Chem. 35:1993;26200-26205.
49. Alcantra O, Obeid L, Hannun Y, Ponka P, Boldt DH. Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-b and PKC-a gene expression and role of the 5′-flanking region of the PKC-b gene in the response to ferric transferrin. Blood. 84:1994;3510-3517.
50. Selden JR, Dolbear F, Clair JH, Miller JE, McGettigan K, Dijohn JA, Dysart GR, Deluca JG. Validation of flow cytometric in vitro DNA repair (UDS) assay in rat hepatocytes. Mutat Res. 315:1994;147-167.
51. Styles J, Elliott BM, Lefevre PA, Robinson M, Pritchard N, Hart D, Ashby J. Irreversible depression in the ratio of tetraploid: diploid liver nuclei in rats treated with 3′-methyl-4-dimethylaminoazobenzene (3′M). Carcinogenesis. 6:1985;21-28.
52. Flood AE, Rutherford PP, Weston EW. Nuclear ploidy in mammalian parenchymal liver cells. Nature. 214:1967;1050-1051.
53. Fukuchi K, Tomoyasu S, Tsuruoka N, Gomi K. Iron deprivation-induced apoptosis in HL-60 cells. FEBS Lett. 350:1994;139-142.
54. Hileti D, Panayiotidis P, Hoffbrand V. Iron chelators induce apoptosis in proliferating cells. Br J Haematol. 89:1995;181-187.
55. Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology. 11:1990;127-137.
56. Shires TK. Iron-induced DNA damage and synthesis in isolated rat liver nuclei. Biochem J. 205:1982;321-329.
57. Kasai H, Nishimura S. Formation of 8-hydroxyguanosine in DNA by oxygen radicals and its biological significance. Sies H. Oxidative Stress, Oxidants and Antioxidants. 1991;99-116 Academic Press, New York.
58. Box HC, Freund HG, Budzinski EE, Wallace JC, Macubbin AE. Free radical-induced double base lesions. Radiat Res. 141:1995;91-94.
59. Morel I, Lescoat G, Cillard J, Pasdeloup N, Brissot P, Cillard P. Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Biochem Pharmacol. 39:1990;1647-1655.
60. Loréal O, Deugnier Y, Moirand R, Lauvin L, Guyader D, Jouanolle H, Turlin B, Lescoat G, Brissot P. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J Hepatol. 16:1992;122-127.
61. Deugnier Y, Loréal O, Turlin B, Guyader d, Jouanolle H, Moirand R, Jacquelinet C, Brissot P. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology. 102:1992;2050-2059.